07:48 AM EDT, 10/28/2024 (MT Newswires) -- Evoke Pharma ( EVOK ) shares surged more than 130% pre-bell Monday after the company reported results from a real-world study showing significant statistical improvement for its diabetic gastroparesis nasal therapy over oral metoclopramide.

Monte Rosa Therapeutics ( GLUE ) shares advanced 42% after the company said it secured a global license deal with Novartis (NVS) to advance therapies for multiple immune-mediated conditions.

Revance Therapeutics ( RVNC ) shares rose 22%, rebounding from Friday's slide.

Focus Impact Acquisition ( FIAC ) shares were up 15%, adding to Friday's gains.

MEI Pharma ( MEIP ) shares increased 12% following a muted session.

Price: 11.75, Change: +6.62, Percent Change: +129.04